Showing results (21-30 of 185) with videos related to

Sort By:
Pageof 19
Gastroenterology|October 11, 2016
Management Strategies to Improve Outcomes of Patients With Inflammatory Bowel DiseasesJean-Frederic Colombel, Neeraj Narula, Laurent Peyrin-Biroulet
Inflammatory Bowel Diseases|February 8, 2023
Histological Remission Placebo Rates in Ulcerative Colitis Trials: A Systematic Review and Meta-analysisMichael Youssef, Kelly Dong, So Jeong Lee, et al.
The American Journal of Medicine|July 31, 2012
Are patients with inflammatory bowel disease at increased risk of coronary artery disease?Sumeet Gandhi, Neeraj Narula, John K Marshall, et al.
Journal of Crohn'S & Colitis|August 24, 2022
Time to Endorse A Sensitive Method for Scoring Endoscopic Activity of Ulcerative Colitis in Clinical ResearchNeeraj Narula, Shahin Merat, David Liu, et al.
Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society|August 28, 2023
Vedolizumab does not increase risk of clostridium difficile infection in patients with inflammatory bowel disease using vedolizumab: A retrospective cohort studyAbdulaziz Saad Alshahrani, Danah Mohammad, Mohammad Attieh Alzahrani, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|September 21, 2012
An audit of influenza vaccination status in adults with inflammatory bowel diseaseNeeraj Narula, Amit S Dhillon, Usha Chauhan, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 2, 2016
Mucosal Healing Is Associated With Improved Long-term Outcomes of Patients With Ulcerative Colitis: A Systematic Review and Meta-analysisShailja C Shah, Jean-Frederic Colombel, Bruce E Sands, et al.
Inflammatory Bowel Diseases|August 20, 2020
Body Mass Index Does Not Impact Clinical Efficacy of Ustekinumab in Crohn's Disease: A Post Hoc Analysis of the IM-UNITI TrialEmily C L Wong, John K Marshall, Walter Reinisch, et al.
Pageof 19